More than 200 insulin pump users injured after app causes malfunction
May 09, 2024
The US Food and Drug Administration has issued a Class 1 recall — its most urgent kind — for an IOS app linked to a specific kind of insulin pump used by people with diabetes.
Coverage for Medicare’s e-visits still available, though few patients use service
By
Kristen Fischer
Apr 16, 2024
E-visits, which drew expanded coverage during the pandemic still are available but not used often, a new study shows.
RPM landscape in 2024: centralized care teams required to realize potential of monitoring tech, experts...
By
Aaron Dorman
Feb 15, 2024
Having care teams solely dedicated to RPM data will both address patient needs and avoid “alert fatigue,” a new report suggests.
First OTC continuous blood glucose monitor cleared for marketing by FDA
Mar 06, 2024
The Dexcom Stelo Glucose Biosensor System is intended for people aged 18 or more years who have type 2 diabetes but do not take insulin.
In trial, researchers test EHR alerts to lower harmful screenings, overtreatment in seniors
By
Kristen Fischer
Feb 15, 2024
Researchers devised a new way to ensure that older adults aren’t being overtreated or tested needlessly via unnecessary screenings.
FDA warns of smartwatches that claim to measure glucose levels
Feb 22, 2024
Many companies are illegally marketing smartwatch or smart ring devices that claim to measure blood glucose without piercing the skin.